11085 Torreyana Road
San Diego, CA 92121
November 1, 2021
VIA EDGAR
U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549
| Attn: | Joseph McCann, Office of Life Sciences |
| Re: | BioAtla, Inc. |
Registration Statement on Form S-1
Filed October 22, 2021
File No. 333-260440
REQUEST FOR ACCELERATION OF EFFECTIVENESS
Acceleration Request
| Requested Date: | November 3, 2021 | |
| Requested Time: | 4:00 p.m. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioAtla, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the Company’s Registration Statement on Form S-1 (File No. 333-260440) effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Company hereby authorizes Niki Fang, who is an attorney with the Company’s outside legal counsel, Orrick, Herrington & Sutcliffe LLP, to orally modify or withdraw this request for acceleration.
The Company requests that it be notified of such effectiveness by a telephone call to Ms. Fang at (415) 773-5540.
[Signature page follows]
| Sincerely, | ||
| BIOATLA, INC. | ||
| By: | /s/ Richard Waldron | |
| Name: Richard Waldron | ||
| Title: Chief Financial Officer | ||
| cc: | Niki Fang, Esq., Orrick, Herrington & Sutcliffe LLP |